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ABSTRACT
Some 2–5% of germ cell tumours are of extragonadal origin, with a retroperitoneal location being very rare. The majority of retroperitoneal 
germ cell tumours have metastasized from a testicular tumour. These tumours are diagnosed incidentally or symptomatically and nearly all 
present with high alpha-fetoprotein and lactate dehydrogenase levels.
We describe the unusual case of a 31-year-old man with a yolk-sac, retroperitoneal germ cell tumour, with normal serum alpha-fetoprotein 
and lactate dehydrogenase levels, which has not previously been described. A testicular tumour was excluded by physical examination and 
additional tests. Our diagnosis was based on a high level of suspicion and histopathological results. As far as we know, this is the first case 
described with these characteristics.
LEARNING POINTS
• Extragonadal germ cell tumours are rare but can have fatal consequences if undiagnosed.
• The usual laboratory markers of the disease were absent in our patient.
• A high level of suspicion is required for diagnosis and close follow-up is required.
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CASE DESCRIPTION 
We describe the case of a 31-year old man who was otherwise healthy apart from right low back pain for the previous 4 months, at the 
L1–L3 level, which had worsened in the last 2 weeks, was severe (8/10) and radiated to the right groin. There was no history of trauma. The 
patient described the pain as aching for most of the time with occasional stabbing pain, which was neither alleviated nor aggravated by rest, 
exercise, heat, cold or NSAIDs. He denied fever, sweating, urinary, respiratory or intestinal symptoms, numbness or sphincter incontinence. 
On observation, the patient was pale, but his vital signs were within the normal range. Laségue’s sign was absent bilaterally and the patient’s 
walk was unaffected. His testicles had normal dimensions and were symmetrical, but the right testicle was tender on palpation, without any 
inflammatory signs. 
Laboratory results were normal except for the presence of mild normochromic normocytic anaemia (haemoglobin 12.6 g/dl) due to low folic 
acid. His peripheral blood smear, iron kinetics and B12 vitamin levels were normal. His proteinogram was unremarkable. He tested negative 
for HIV and hepatitis. His lactate dehydrogenase, human chorionic gonadotropin and alpha-fetoprotein levels were normal. 
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His testicular ultrasound revealed normal testicles which were relatively symmetrical and had a regular outline. The testicles had a 
homogeneous echotexture, without focal lesions bilaterally, and with normal Doppler US, excluding the need for a testicular biopsy. 
A thoracic, abdominal and pelvic CT scan revealed a right paravertebral space-occupying mass measuring 58×33 mm which displaced the 
right anterior crus of the diaphragm, and was well defined and homogeneous, and also showed axillary adenomegaly bilaterally of less than 
1 cm. A CT-guided biopsy of the mass was performed. Histological examination showed a primary yolk-sac tumour of the retroperitoneal 
region cT0N3M0S0, stage IIC, a good International Germ Cell Consensus Classification (IGCCCG) prognosis and a good ECOG performance 
status of 0. Immunohistochemical stains for placental alpha-fetoprotein and cytokeratin AE1/AE3, CAM 5.2, CD56 and CD117 were positive 
in the tumour cells.
The patient’s pain was controlled with pregabalin, tapentadol and paracetamol.
Sperm was collected from the patient for storage before the initiation of three cycles of BEP (bleomycin, etoposide and cisplatin). 
The patient’s follow-up will consist of cancer staging at 3-month intervals for the first year, high-dose chemotherapy, resection surgery of 
the residual mass, retroperitoneal lymph node dissection and preventive orchiectomy.
DISCUSSION 
The unusual specific location of the pain as well as its characteristics, which did not seem to be due to lumbago, alerted us to seek another 
diagnosis.
Primary GCT of extragonadal origin without a primary gonadal lesion are rare[1,3]. In our patient, there was no clinical, analytical or imaging 
evidence of a testicular tumour, but close follow-up will be needed to check for testicular cancer. Nevertheless we collected sperm before 
chemotherapy as preservation of fertility is particularly important in young patients[8].
There are no treatment guidelines for extragonadal variants of GCT so therapy is mainly extrapolated from that for gonadal GCT[6]. As 
retroperitoneal GCT have comparable clinical behaviour to gonadal GCT[1], treatment is nearly the same, with the exception of orchidectomy[4], 
which might however be performed to exclude a source of recurrence and metastases from occult disease[4]. 
The majority of extragonadal tumours can be cured with chemotherapy. For retroperitoneal non-seminomatous GCT, the treatment is 
cisplatin-based chemotherapy (as would be used for a testicular non-seminomatous GCT)[10]. 
However, patients with extragonadal GCT have a worse prognosis than those with testicular GCT within the same prognostic IGCCCG group, 
or than those with seminomas[9]. Patients with retroperitoneal non-seminomatous GCT have a 10% chance of developing testicular cancer 
within 10 years, which highlights the importance of close follow-up for a long period[9]. 
On the other hand, patients with primary retroperitoneal GCT have longer survival than those with relapsed metastatic testicular GCT[1,9], 
only 30% of whom can be cured with high-dose chemotherapy[1].
Yolk-sac tumours, the histological type in our clinical case, are grey tumours with areas of necrosis and haemorrhage[6]. Microscopically, 
different patterns that recapitulate the yolk sac are seen but one should predominate[6]. Yolk-sac tumours are characterized by high serum 
alpha-fetoprotein levels[7], which however were not seen in our patient. This tumour marker is an important follow-up guide for treatment 
response, recurrence or metastasis. We do not know if normal alpha-fetoprotein levels can affect treatment responsive or prognosis. We will 
follow a strict and close follow-up protocol with clinical examination and complementary examinations to help us answer those questions.
To our knowledge this is the first case described with a primary retroperitoneal yolk-sac tumour with a normal serum alpha-fetoprotein level. 
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